Clinical trial Recruiting at 1 site Observational Ages 40 and up

Transarterial microembolization (TAME) for inflamed knee osteoarthritis

Official title: "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology: Prospective Observational Study."

Run by Istituto Ortopedico Rizzoli · NCT07140367 · Data updated 2026-11-12

This project will try selective arterial embolization (TAME) to reduce chronic pain in adults with moderate inflammatory knee osteoarthritis who have not improved after at least three months of conservative care.

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment43 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna, Bologna)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedSeptember 1, 2029
Study endsSeptember 1, 2031
Registry record updatedApril 7, 2026
Trial IDNCT07140367 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 40 with moderate (KL 2-3) knee osteoarthritis with inflammatory signs, persistent moderate-to-severe pain (VAS >4), and documented failure of at least three months of conservative therapies.

Probably not a fit

Patients with severe end-stage OA, rheumatic diseases, recent knee trauma, active malignancy, or other exclusion conditions listed by the investigators are less likely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll 43 patients with moderate (Kellgren-Lawrence grade 2-3) knee osteoarthritis with inflammatory features and persistent pain despite at least three months of conservative therapy. Enrolled patients will undergo transarterial microembolization (selective arterial embolization) and be followed with clinical evaluations at 1, 3, 6, 12, and 24 months or until dropout. Outcomes will focus on pain, functional status, and safety signals after the embolization procedure. The protocol uses multidisciplinary eligibility review and is conducted at IRCCS Istituto Ortopedico Rizzoli in Bologna.

Why it matters

Potential benefit: If successful, the procedure could reduce knee pain and improve function, potentially delaying or reducing the need for knee replacement surgery.

How similar studies have gone: Related techniques such as genicular artery embolization have shown promising pain reduction in small series, but evidence remains limited and not yet definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Patients with degenerative knee disease:

1. Age over 40 years;
2. Moderate knee OA (grade 2-3 according to the Kellgren-Lawrence score) for which an indication for total knee arthroplasty surgery has already been given;
3. Knee OA with an inflammatory component (night pain, pain at rest, recurrent episodes of effusion, swelling and/or redness);
4. Persistent and moderate or severe knee pain (VAS score \> 4);
5. Failure after at least 3 months of conservative therapies (e.g., physical therapy, drug therapy with NSAIDs and pain relievers, hyaluronic acid infiltration, corticosteroids, or orthobiologics).
6. Signature of informed consent
7. Case declared eligible for treatment following discussion at internal multidisciplinary meeting on degenerative-inflammatory disease

Exclusion Criteria:

1. Mentally incompetent patients;
2. Patients with trauma in the 6 months prior to treatment;
3. Patients with malignant neoplasms;
4. Patients with rheumatic diseases;
5. Patients on anticoagulant-antiaggregant therapy (including if therapy can be discontinued 5 days earlier);
6. Patients abusing alcoholic beverages, drugs, or medications;
7. Patients undergoing surgery of the affected knee in the previous 12 months;
8. INR \<2;
9. Platelet count \<30,000;
10. Renal function: GFR\<30ml/min;
11. Pregnancy;
12. Allergy to iodinated contrast.
13. Ineligibility to perform MRI examination.

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.